ScholarIQanswers from OpenAlex

Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases

PaperCitations, authors & open-access status

Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases have?

ScholarIQcitation count

Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases has 217 citations in the OpenAlex counts ScholarIQ stores.

When was Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases published?

ScholarIQyear

Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases has 2018 year in the ScholarIQ index.

What is the open-access status of Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases?

ScholarIQoa status

Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases has diamond oa status in the ScholarIQ index.

What is the DOI of Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases?

ScholarIQdoi

The DOI for Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases is on the source record.

What is the PMID of Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases?

ScholarIQpmid

The PMID for Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases is on the source record.

What is the OpenAlex record for Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases?

ScholarIQopenalex

The OpenAlex for Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial